Abstract:Colorectal cancer (CRC) is considered the world's fourth most deadly cancer. Its metastasis is associated with poor prognosis and weakens the effects of treatment. However, the potential molecular mechanisms and key genes involved in CRC metastasis have remained to be comprehensively elucidated. The objective of the present study was to identify the key genes and molecular pathways underlying CRC metastasis. Differentially expressed genes (DEGs) between primary CRC tissues and metastatic CRC were identified by analyzing the GSE2509 dataset from the Gene Expression Omnibus database. Subsequently, the DEGs were subjected to Gene Ontology (GO) term and Kyoto Encyclopedia of Genes and Genome (KEGG) pathway enrichment analyses via the Database for Annotation, Visualization and Integrated Discovery (DAVID). Next, the top ten hub genes were identified in a protein-protein interaction (PPI) network. Sub-network and pathway enrichment analysis were respectively performed with the plugin MCODE and DAVID. Finally, reverse transcription-quantitative polymerase chain reaction assays were performed to corroborate the expression levels of the top five potential metastasis-associated genes in the clinical samples of CRC patients. A total of 7,384 DEGs were obtained, among which 3,949 were upregulated and 3,435 were downregulated. GO and KEGG enrichment analyses identified numerous possible biological processes and pathways that may have a role in the metastasis of CRC. The leading ten hub genes, recognized from the PPI, were epidermal growth factor receptor (EGFR), Has proto-oncogene GTPase (HRas), Wnt family member 5A (Wnt5a), serine/threonine kinase 1 (Akt1), cyclin-dependent kinase inhibitor 1A (CDKN1a), early growth response 1, Ras homolog family member A, cyclin D1 and Ras-related C3 botulinum toxin substrate 1. Sub-network analysis disclosed the most prominent three modules. Ultimately, EGFR, HRas and Akt1 were verified to be upregulated DEGs, while Wnt5a and CDKN1a were downregulated DEGs when compared with the primary controls. In conclusion, the present study revealed several key genes and relevant molecular mechanisms that may enhance the current understanding of CRC metastasis, making them significant potential foci for the discovery of further CRC treatments.

Advances in molecular mechanisms of hepatic metastasis in colorectal cancer

Mechanisms Regulating Colorectal Cancer Cell Metastasis into Liver (Review).

A Comprehensive Look at the Role of Hyperlipidemia in Promoting Colorectal Cancer Liver Metastasis

Delineating the Underlying Molecular Mechanisms and Key Genes Involved in Metastasis of Colorectal Cancer Via Bioinformatics Analysis

Colorectal liver metastasis: molecular mechanism and interventional therapy

Advances in molecular biology and clinical practice of rectal liver metastases

Mechanism and Targeted Therapy of Liver Metastases of Colorectal Cancer

Recent advances in colorectal cancer liver metastases

Mechanisms Involved in Breast Cancer Liver Metastasis

The updates on metastatic mechanism and treatment of colorectal cancer

Molecular Mechanisms of Colorectal Liver Metastases

Advances in Treatment of Liver Metastasis of Colorectal Cancer

Liver Immune Microenvironment and Metastasis from Colorectal Cancer-Pathogenesis and Therapeutic Perspectives

Treatment progression in colorectal cancer liver metastasis

Epithelial–mesenchymal transition in colorectal cancer metastasis: A system review

Potential molecular mechanisms and clinical progress in liver metastasis of breast cancer

Metastasis organotropism in colorectal cancer: advancing toward innovative therapies

Cellular and molecular mechanisms of gastrointestinal cancer liver metastases and drug resistance

Molecular mechanisms investigation for liver metastasis of colorectal cancer by combined bioinformatic gene expression profile analysis

Organ-specific cholesterol metabolic aberration fuels liver metastasis of colorectal cancer

Multi-stage mechanisms of tumor metastasis and therapeutic strategies